Tilray Shares Jump On The Back Of Novartis Partnership

Canadian cannabis producer Tilray Inc. TLRY surged Tuesday morning on the announced partnership with pharmaceutical giant Novartis AG NVS.

What Happened

Tilray said that its subsidiary, Tilray Canada, has entered into an agreement with Sandoz AG, part of the Novartis AG. Under the terms of global framework agreement, Sandoz may help Tilray commercialize its non-smokable and non-combustible medical cannabis products around the world. Tilray and Sandoz might develop medical marijuana brands and products. In addition, Tilray will supply Sandoz with medical marijuana products.

The agreement builds on top of the previous alliance between Tilray Canada and Sandoz Canada, which was announced in March.

Why It's Important

The partnership between Tilray Canada and Sandoz will help both companies leverage their strengths as cannabis' popularity spreads across the world. There are 30 countries worldwide that allow medical marijuana to one degree or another. Tilray already has operations in 12 countries, including Australia, New Zealand, Germany, Portugal and Latin America.

In this way, the partnership will allow Tilray expand into new markets and develop new products in collaboration with the subsidiary of one of the largest pharmaceutical companies.

Cannabis investors can't miss the Benzinga Cannabis Capital Conference, the No. 1 networking event for institutional capital and the leading cannabis companies. Secure your tickets here before they run out.

What's Next

The partnership between a large cannabis company and a pharmaceutical giant will certainly provide a boost to the medical marijuana segment, not only by increasing availability of medical-grade pot around the globe, but also through additional capital flowing in research and development, which could potentially result in more cannabis-based drugs.

At time of publication, Tilray traded up 8.7 percent at $71.65 per share.

Related Links:

Tilray Signs LOI To Buy American Hemp-Derived CBD

Farm Bill Effect: Impact On U.S. And Global Hemp Markets

Posted In: SandozTilray CanadaCannabisNewsHealth CareMarketsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.